NDAs Advisory Board Members Prof. Mira Pavlovic, HTA Expert and Prof. Beatriz Silva Lima, Non-clinical Expert, will participate in the Value, Access and Regulatory Strategy Workshop arranged by DIA at Radisson Blu Hotel, Basel, Switzerland, 25-26 October 2017.

Professor Pavlovic is on the programme committee as well as chairing session three ‘Early dialogue between regulators and HTA (and payers & patients)’. Professor Silva Lima will present in session four ‘Patient’s role in the regulatory and HTA process’.

All stakeholders, including leaders across industry and health authorities, agree that finding answers to market access is critical to delivering breakthrough medicines to patients. Unfortunately, policies and practices do not always marry up. This meeting will bring together professionals working with regulatory and value strategies, policymakers, developers, and the patients as end-users, to keep you ahead of the game with practical solutions.

To find out more click here.


Mira Pavlovic-Ganascia

Advisory Board Member

Read more

Beatriz Silva Lima

Advisory Board Member

Read more



Stay up to date

Contact us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World

  • This field is for validation purposes and should be left unchanged.